Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in BMC Cancer

Retrieve available abstracts of 267 articles:
HTML format

Single Articles

    November 2022
  1. SPRAVE T, Gkika E, Verma V, Grosu AL, et al
    Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study.
    BMC Cancer. 2022;22:1236.
    PubMed     Abstract available

  2. LUO X, Huang X, Luo J, Xiao J, et al
    Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial.
    BMC Cancer. 2022;22:1235.
    PubMed     Abstract available

  3. YANG XL, Zhang LL, Kou J, Zhou GQ, et al
    Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure.
    BMC Cancer. 2022;22:1230.
    PubMed     Abstract available

  4. KAO HF, Huang HC, Liao BC, Hong RL, et al
    Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis.
    BMC Cancer. 2022;22:1228.
    PubMed     Abstract available

  5. DUPONT M, Carlier C, Gower-Rousseau C, Barbier-Lider P, et al
    Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
    BMC Cancer. 2022;22:1219.
    PubMed     Abstract available

  6. CAO Y, Dong H, Li G, Wei H, et al
    Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma.
    BMC Cancer. 2022;22:1209.
    PubMed     Abstract available

  7. WANG J, Wang N, Zheng Z, Che Y, et al
    Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma.
    BMC Cancer. 2022;22:1208.
    PubMed     Abstract available

  8. YEH TL, Hsu MS, Hsu HY, Tsai MC, et al
    Risk of cardiovascular diseases in cancer patients: A nationwide representative cohort study in Taiwan.
    BMC Cancer. 2022;22:1198.
    PubMed     Abstract available

  9. YANG Y, Tang P, Ma M, Zhang H, et al
    Comparison of clinicopathological features and prognostic significance between synchronous multiple primary and solitary esophageal squamous cell carcinomas.
    BMC Cancer. 2022;22:1191.
    PubMed     Abstract available

  10. YANG Z, Lin H, Wang Z, Rong L, et al
    The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment.
    BMC Cancer. 2022;22:1180.
    PubMed     Abstract available

  11. KAIDA H, Yasuda T, Shiraishi O, Kato H, et al
    The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1176.
    PubMed     Abstract available

  12. SAWICKI CM, Janal MN, Nicholson SJ, Wu AK, et al
    Oral cancer patients experience mechanical and chemical sensitivity at the site of the cancer.
    BMC Cancer. 2022;22:1165.
    PubMed     Abstract available

  13. INOKAWA Y, Hayashi M, Begum S, Noordhuis MG, et al
    High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
    BMC Cancer. 2022;22:1146.
    PubMed     Abstract available

  14. CARPEN T, Gille E, Hammarstedt-Nordenvall L, Hansen J, et al
    Occupational risk variation of nasopharyngeal cancer in the Nordic countries.
    BMC Cancer. 2022;22:1130.
    PubMed     Abstract available

  15. WANG L, Yao B, Yang J, Tian Z, et al
    Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
    BMC Cancer. 2022;22:1131.
    PubMed     Abstract available

  16. LIU SL, Li XY, Sun XS, Peng JY, et al
    Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
    BMC Cancer. 2022;22:1129.
    PubMed     Abstract available

  17. GU P, Ling B, Ma W, Zhang J, et al
    Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
    BMC Cancer. 2022;22:1116.
    PubMed     Abstract available

    October 2022
  18. SAADAAT R, Abdul-Ghafar J, Hanifi AN, Khalid S, et al
    Risk factors associated with esophageal cancers, diagnosed at tertiary level in Afghanistan: a descriptive cross-sectional study.
    BMC Cancer. 2022;22:1112.
    PubMed     Abstract available

  19. ALMANGUSH A, Bello IO, Elseragy A, Hagstrom J, et al
    Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
    BMC Cancer. 2022;22:1108.
    PubMed     Abstract available

  20. FENG Y, Wang B, Pan L, Yao B, et al
    Study protocol for artificial intelligence-assisted sponge cytology as pre-endoscopy screening for early esophegeal squmaous epithelial lesions in China.
    BMC Cancer. 2022;22:1105.
    PubMed     Abstract available

  21. NISHIMURA A, Yokota T, Hamauchi S, Onozawa Y, et al
    Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
    BMC Cancer. 2022;22:1101.
    PubMed     Abstract available

  22. SHEN Y, Huang Q, Ji M, Hsueh CY, et al
    Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas.
    BMC Cancer. 2022;22:1093.
    PubMed     Abstract available

  23. TANG CL, Tsai WC, Lee JY, Wang YK, et al
    Higher pre-treatment skin sympathetic nerve activity and elevated resting heart rate after chemoradiotherapy predict worse esophageal cancer outcomes.
    BMC Cancer. 2022;22:1086.
    PubMed     Abstract available

  24. HUNG CJ, Kang BH, Chang KM, Kang YY, et al
    Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy.
    BMC Cancer. 2022;22:1084.
    PubMed     Abstract available

  25. KIM SI, Woo SR, Noh JK, Lee MK, et al
    Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:1077.
    PubMed     Abstract available

  26. YURA M, Fukuda K, Matsuda S, Irino T, et al
    Effects of let-7a microRNA and C-C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1064.
    PubMed     Abstract available

    September 2022
  27. CUI D, Cui X, Xu X, Zhang W, et al
    Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
    BMC Cancer. 2022;22:1027.
    PubMed     Abstract available

  28. VOTAVA M, Bartolini R, Capkova L, Smetanova J, et al
    The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy.
    BMC Cancer. 2022;22:1021.
    PubMed     Abstract available

  29. HUANG Q, Ye M, Li F, Lin L, et al
    Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: a 3-year follow-up retrospective study.
    BMC Cancer. 2022;22:1019.
    PubMed     Abstract available

  30. PIEK MW, de Boer JP, van Duijnhoven F, van der Wal JE, et al
    The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
    BMC Cancer. 2022;22:1018.
    PubMed     Abstract available

  31. ZHANG H, Pan E, Zhang Y, Zhao C, et al
    LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis.
    BMC Cancer. 2022;22:1017.
    PubMed     Abstract available

  32. GORPHE P, Blanchard P, Garcia GCTE, Classe M, et al
    2011-2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France.
    BMC Cancer. 2022;22:1000.
    PubMed     Abstract available

  33. RADES D, Zwaan I, Cacicedo J, Bruchhage KL, et al
    Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02).
    BMC Cancer. 2022;22:989.
    PubMed     Abstract available

  34. GAO TT, Shan JH, Yang YX, Zhang ZW, et al
    Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis.
    BMC Cancer. 2022;22:992.
    PubMed     Abstract available

  35. AHMED S, Khan S, Qureshi MA, Bukhari U, et al
    Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC.
    BMC Cancer. 2022;22:990.
    PubMed     Abstract available

  36. LIANG MX, Fei YJ, Yang K, Tang WJ, et al
    Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
    BMC Cancer. 2022;22:954.
    PubMed     Abstract available

  37. STAUDACHER JJ, Arnold A, Kuhl AA, Potzsch M, et al
    Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas.
    BMC Cancer. 2022;22:953.
    PubMed     Abstract available

  38. XU T, Liu X
    Oleuropein inhibits invasion of squamous cell carcinoma of the head and neck through TGF-beta1 signaling pathway.
    BMC Cancer. 2022;22:942.
    PubMed     Abstract available

    August 2022
  39. PENG C, Yi D, Zhou Y, Yao J, et al
    Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography.
    BMC Cancer. 2022;22:938.
    PubMed     Abstract available

  40. WANG C, Sun G, Wang H, Dai L, et al
    Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:932.
    PubMed     Abstract available

  41. LIN Z, Zeng H, Xiong W, Li J, et al
    Whether the infracardiac bursa protect right pleura during laparoscopic radical operation of Siewert type II adenocarcinoma of esophagogastric junction?
    BMC Cancer. 2022;22:927.
    PubMed     Abstract available

  42. HU ZY, Gou JX, Cai M, Zhang YE, et al
    Translation and validation of M.D. Anderson Symptom Inventory-Thyroid Cancer module in Chinese thyroid cancer patients: a cross-sectional and methodological study.
    BMC Cancer. 2022;22:924.
    PubMed     Abstract available

  43. EL MASHED S, O'Donovan TR, Kay E, O'Grady A, et al
    Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.
    BMC Cancer. 2022;22:908.
    PubMed     Abstract available

  44. GONDHOWIARDJO SA, Adham M, Rachmadi L, Atmakusuma TD, et al
    Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer.
    BMC Cancer. 2022;22:887.
    PubMed     Abstract available

  45. GUO SS, Chen YZ, Liu LT, Liu RP, et al
    Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:880.
    PubMed     Abstract available

  46. YUAN X, Yang H, Zeng F, Zhou S, et al
    Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA.
    BMC Cancer. 2022;22:858.
    PubMed     Abstract available

  47. WANG CK, Ho CF, Niu KY, Wu CC, et al
    Risk factors for rebleeding and long-term outcomes in patients with head and neck cancer bleeding: a multicenter study.
    BMC Cancer. 2022;22:841.
    PubMed     Abstract available

    July 2022
  48. SUN R, Zhou Y, Cai Y, Shui C, et al
    circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway.
    BMC Cancer. 2022;22:799.
    PubMed     Abstract available

  49. CHEN C, Luo L, Xu C, Yang X, et al
    Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes.
    BMC Cancer. 2022;22:790.
    PubMed     Abstract available

  50. MANDIC R, Marquardt A, Terhorst P, Ali U, et al
    The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC.
    BMC Cancer. 2022;22:785.
    PubMed     Abstract available

  51. KAWATA-SHIMAMURA Y, Eguchi H, Kawabata-Iwakawa R, Nakahira M, et al
    Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents.
    BMC Cancer. 2022;22:779.
    PubMed     Abstract available

  52. ISSA M, Klamer BG, Mladkova N, Laliotis GI, et al
    Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
    BMC Cancer. 2022;22:767.
    PubMed     Abstract available

  53. FENG WH, Chen YY, Kuo YS, Lin KH, et al
    Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment.
    BMC Cancer. 2022;22:768.
    PubMed     Abstract available

  54. LIN J, Qiu Y, Zheng X, Dai Y, et al
    The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
    BMC Cancer. 2022;22:756.
    PubMed     Abstract available

  55. LI J, Tang LL, Ma J
    Correction: Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    BMC Cancer. 2022;22:755.

  56. YU E, Allan AL, Sanatani M, Lewis D, et al
    Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
    BMC Cancer. 2022;22:746.
    PubMed     Abstract available

  57. CZAJKOWSKI M, Kaemmerer D, Sanger J, Sauter G, et al
    Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
    BMC Cancer. 2022;22:740.
    PubMed     Abstract available

  58. GUO J, Yang Q, Wei S, Shao J, et al
    Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:745.
    PubMed     Abstract available

  59. PEI W, Wang C, Liao H, Chen X, et al
    MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:739.
    PubMed     Abstract available

    June 2022
  60. HIRAHARA N, Matsubara T, Kaji S, Hayashi H, et al
    Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.
    BMC Cancer. 2022;22:718.
    PubMed     Abstract available

  61. ZHU J, Fang R, Pan Z, Qian X, et al
    Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:716.
    PubMed     Abstract available

  62. LI J, Tang LL, Ma J
    Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    BMC Cancer. 2022;22:714.
    PubMed     Abstract available

  63. ZHOU M, Yang W, Xuan Y, Zou W, et al
    A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRac
    BMC Cancer. 2022;22:710.
    PubMed     Abstract available

  64. ALMADORI G, Coli A, De Corso E, Mele DA, et al
    Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
    BMC Cancer. 2022;22:704.
    PubMed     Abstract available

  65. LIN Z, Rao W, Xiang Z, Zeng Q, et al
    Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:696.
    PubMed     Abstract available

  66. DEGUCHI S, Tanaka H, Suzuki S, Natsuki S, et al
    Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:699.
    PubMed     Abstract available

  67. SHAVER AL, Platek ME, Singh AK, Ma SJ, et al
    Effect of musculature on mortality, a retrospective cohort study.
    BMC Cancer. 2022;22:688.
    PubMed     Abstract available

  68. ZHOU G, Zhang S, Jin M, Hu S, et al
    Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
    BMC Cancer. 2022;22:667.
    PubMed     Abstract available

  69. SHI J, Wang L, Yao N, Sun L, et al
    The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis.
    BMC Cancer. 2022;22:658.
    PubMed     Abstract available

  70. CAO Y, Han D, Yang S, Shi Y, et al
    Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
    BMC Cancer. 2022;22:650.
    PubMed     Abstract available

  71. TSAI PC, Chien HC, Hsu PK, Hung JJ, et al
    Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
    BMC Cancer. 2022;22:637.
    PubMed     Abstract available

  72. MAAHS L, Ghanem AI, Gutta R, Tang A, et al
    Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.
    BMC Cancer. 2022;22:626.
    PubMed     Abstract available

  73. LI Z, Li C, Yang D, Song J, et al
    Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2022;22:616.
    PubMed     Abstract available

  74. LO WC, Chang CM, Wu CY, Hsieh CH, et al
    A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation.
    BMC Cancer. 2022;22:615.
    PubMed     Abstract available

  75. NELLIGAN NM, Bender MR, Feltus FA
    Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning.
    BMC Cancer. 2022;22:612.
    PubMed     Abstract available

  76. LUO QW, Gao S, Lv X, Li SJ, et al
    A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:606.
    PubMed     Abstract available

    May 2022
  77. ZOU X, Zhou Q, Nie Y, Gou J, et al
    Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
    BMC Cancer. 2022;22:595.
    PubMed     Abstract available

  78. CAI Z, Tang B, Chen L, Lei W, et al
    Mast cell marker gene signature in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:577.
    PubMed     Abstract available

  79. MANN C, Berlth F, Hadzijusufovic E, Tagkalos E, et al
    Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity.
    BMC Cancer. 2022;22:579.
    PubMed     Abstract available

  80. LIN C, Li M, Lin N, Zong J, et al
    RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:549.
    PubMed     Abstract available

  81. QIAN L, Ni T, Fei B, Sun H, et al
    An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    BMC Cancer. 2022;22:545.
    PubMed     Abstract available

  82. HUO Z, Fu S, Ma C, Sheng S, et al
    Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:535.
    PubMed     Abstract available

  83. DOS SANTOS M, Lequesne J, Leconte A, Corbinais S, et al
    Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
    BMC Cancer. 2022;22:537.
    PubMed     Abstract available

  84. CAI M, Zheng Z, Bai Z, Ouyang K, et al
    Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
    BMC Cancer. 2022;22:530.
    PubMed     Abstract available

  85. LU XJD, Jackson E, Chew J, Nguyen S, et al
    Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers.
    BMC Cancer. 2022;22:513.
    PubMed     Abstract available

  86. JIN YN, Xia TL, Mai DM, Yao JJ, et al
    The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study.
    BMC Cancer. 2022;22:505.
    PubMed     Abstract available

  87. YANG Y, Zhu L, Cheng Y, Liu Z, et al
    Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).
    BMC Cancer. 2022;22:506.
    PubMed     Abstract available

  88. QIU X, Wu H, Xu T, Xie S, et al
    Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:495.
    PubMed     Abstract available

    April 2022
  89. REN L, Li P, Li Z, Chen Q, et al
    AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells.
    BMC Cancer. 2022;22:465.
    PubMed     Abstract available

  90. ZHANG Z, Zhang X, Yin Y, Zhao S, et al
    Integrating BRAF(V600E) mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.
    BMC Cancer. 2022;22:461.
    PubMed     Abstract available

  91. HERTEL M, Hagedorn L, Schmidt-Westhausen AM, Dommisch H, et al
    Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study.
    BMC Cancer. 2022;22:454.
    PubMed     Abstract available

  92. IIDA M, McDaniel NK, Kostecki KL, Welke NB, et al
    AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
    BMC Cancer. 2022;22:447.
    PubMed     Abstract available

  93. RUITER LN, van Dijk BAC, Bruggink AH, Doornaert PAH, et al
    Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands.
    BMC Cancer. 2022;22:444.
    PubMed     Abstract available

  94. DALHAMMAR K, Kristensson J, Falkenback D, Rasmussen BH, et al
    Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer - a comparative study of treatment strategy.
    BMC Cancer. 2022;22:434.
    PubMed     Abstract available

  95. LI PC, Huang RY, Yang YC, Hsieh KP, et al
    Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    BMC Cancer. 2022;22:430.
    PubMed     Abstract available

  96. WANG Q, Wu Z, Zhan T, Fang S, et al
    Retraction Note: Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2022;22:409.

  97. NODA Y, Ishida M, Ueno Y, Fujisawa T, et al
    Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    BMC Cancer. 2022;22:402.
    PubMed     Abstract available

  98. NIPP RD, Shulman E, Smith M, Brown PMC, et al
    Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer.
    BMC Cancer. 2022;22:383.
    PubMed     Abstract available

  99. KUBOTA K, Ito R, Narita N, Tanaka Y, et al
    Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
    BMC Cancer. 2022;22:368.
    PubMed     Abstract available

  100. ZHANG C, Li B, Zhang L, Chen F, et al
    Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
    BMC Cancer. 2022;22:354.
    PubMed     Abstract available

    March 2022
  101. LIU J, Lu J, Li W
    Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:352.
    PubMed     Abstract available

  102. LEE OH, Park YM, Ko SH, Lee K, et al
    Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study.
    BMC Cancer. 2022;22:345.
    PubMed     Abstract available

  103. ZHANG X, Zhang X, Jia Q, Li H, et al
    LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    BMC Cancer. 2022;22:344.
    PubMed     Abstract available

  104. LIANG M, Xiao J, Chen M, Zheng B, et al
    Prognostic variables for conditional survival in patients with esophageal squamous cell carcinoma who underwent minimally invasive surgery.
    BMC Cancer. 2022;22:333.
    PubMed     Abstract available

  105. HUANG D, Li Y, Liu N, Zhang Z, et al
    Retraction Note: Identification of novel signaling components in N,N'-Dinitrosopiperazine-mediated metastasis of nasopharyngeal Carcinoma by quantitative phosphoproteomics.
    BMC Cancer. 2022;22:324.

  106. YANG F, Sun Z, Wang D, Du T, et al
    MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    BMC Cancer. 2022;22:308.
    PubMed     Abstract available

  107. IKAWA T, Ishihara R, Matsueda K, Konishi K, et al
    Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
    BMC Cancer. 2022;22:301.
    PubMed     Abstract available

  108. WANG CP, Chen TC, Hsu WL, Hsiao JR, et al
    Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    BMC Cancer. 2022;22:296.
    PubMed     Abstract available

  109. FENG J, Wang L, Wang L, Yang X, et al
    Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:284.
    PubMed     Abstract available

  110. BOSCOLO-RIZZO P, D'Alessandro A, Polesel J, Borsetto D, et al
    Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:243.
    PubMed     Abstract available

  111. PRUIJSSEN JT, Wenmakers A, Kessels RPC, Piai V, et al
    Long-term cognitive, psychosocial, and neurovascular complications of unilateral head and neck irradiation in young to middle-aged adults.
    BMC Cancer. 2022;22:244.
    PubMed     Abstract available

  112. CHENG J, Zhang R, Yan M, Li Y, et al
    Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:238.
    PubMed     Abstract available

  113. MIDORIKAWA S, Ohtsuru A
    Young people's perspectives of thyroid cancer screening and its harms after the nuclear accident in Fukushima Prefecture: a questionnaire survey indicating opt-out screening strategy of the thyroid examination as an ethical issue.
    BMC Cancer. 2022;22:235.
    PubMed     Abstract available

  114. KOSKINEN AI, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century.
    BMC Cancer. 2022;22:227.
    PubMed     Abstract available

    February 2022
  115. WANG X, Hu B, Chen J, Xie F, et al
    Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.
    BMC Cancer. 2022;22:207.
    PubMed     Abstract available

  116. YE L, Hu L, Liu W, Luo Y, et al
    Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    BMC Cancer. 2022;22:194.

  117. FAN X, Huang Y, Xu P, Min Y, et al
    Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    BMC Cancer. 2022;22:178.
    PubMed     Abstract available

  118. HSIEH CY, Lien MY, Lin CY, Lo WJ, et al
    Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.
    BMC Cancer. 2022;22:169.
    PubMed     Abstract available

  119. VEEN AV, Schiffmann LM, de Groot EM, Bartella I, et al
    The ISCON-trial protocol: laparoscopic ischemic conditioning prior to esophagectomy in patients with esophageal cancer and arterial calcifications.
    BMC Cancer. 2022;22:144.
    PubMed     Abstract available

    January 2022
  120. WU LL, Zhong JD, Zhu JL, Kang L, et al
    Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
    BMC Cancer. 2022;22:118.
    PubMed     Abstract available

  121. ZANG Z, Liu Y, Wang J, Liu Y, et al
    Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.
    BMC Cancer. 2022;22:95.
    PubMed     Abstract available

  122. UENO T, Yatsuoka W, Ishiki H, Miyano K, et al
    Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
    BMC Cancer. 2022;22:90.
    PubMed     Abstract available

  123. BUCKLE GC, Mrema A, Mwachiro M, Ringo Y, et al
    Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
    BMC Cancer. 2022;22:82.
    PubMed     Abstract available

  124. GILLMAN A, Hayes M, Sheaf G, Walshe M, et al
    Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review.
    BMC Cancer. 2022;22:53.
    PubMed     Abstract available

  125. SCHLINTL V, Huemer F, Rinnerthaler G, Melchardt T, et al
    Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
    BMC Cancer. 2022;22:51.
    PubMed     Abstract available

  126. LIN C, Lin S, Zhu L, Lin S, et al
    Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
    BMC Cancer. 2022;22:35.
    PubMed     Abstract available

  127. ROSENBERG AJ, Izumchenko E, Pearson A, Gooi Z, et al
    Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
    BMC Cancer. 2022;22:17.
    PubMed     Abstract available

  128. HENNESSY MA, Hamid M, Keegan NM, Corrigan L, et al
    Metastatic gastroesophageal cancer in older patients - is this patient cohort represented in clinical trials?
    BMC Cancer. 2022;22:3.
    PubMed     Abstract available

    December 2021
  129. HUANG B, Chan EG, Pennathur A, Luketich JD, et al
    The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis.
    BMC Cancer. 2021;21:1334.
    PubMed     Abstract available

  130. XIAO L, Hu Q, Peng Y, Zheng K, et al
    TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts.
    BMC Cancer. 2021;21:1329.
    PubMed     Abstract available

  131. OU D, Wu Y
    The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:1327.
    PubMed     Abstract available

  132. LIU LT, Guo SS, Li H, Lin C, et al
    Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1320.
    PubMed     Abstract available

  133. WUSHOU A, Yibulayin F, Sheng L, Luo Y, et al
    Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database.
    BMC Cancer. 2021;21:1309.
    PubMed     Abstract available

  134. XU N, Lu M, Wang J, Li Y, et al
    Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway.
    BMC Cancer. 2021;21:1307.
    PubMed     Abstract available

  135. ZOUHRY Y, Taibi A, Durand-Fontanier S, Darbas T, et al
    Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
    BMC Cancer. 2021;21:1313.
    PubMed     Abstract available

  136. REN JL, Rojo RD, Perez JVD, Yeung SJ, et al
    Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors.
    BMC Cancer. 2021;21:1304.
    PubMed     Abstract available

  137. PU Y, Li Q, Wang Y, Xu L, et al
    pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
    BMC Cancer. 2021;21:1283.
    PubMed     Abstract available

    November 2021
  138. SUNDE B, Lindblad M, Malmstrom M, Hedberg J, et al
    Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
    BMC Cancer. 2021;21:1277.
    PubMed     Abstract available

  139. ZONG JF, Liang QD, Lu QJ, Liu YH, et al
    Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1274.
    PubMed     Abstract available

  140. YE L, Hu L, Liu W, Luo Y, et al
    Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    BMC Cancer. 2021;21:1250.
    PubMed     Abstract available

  141. ZHANG Y, Chen M, Liu Z, Wang X, et al
    The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma.
    BMC Cancer. 2021;21:1254.
    PubMed     Abstract available

  142. BALK M, Rupp R, Mantsopoulos K, Allner M, et al
    Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    BMC Cancer. 2021;21:1236.
    PubMed     Abstract available

  143. MCILVANNA E, Linden GJ, Craig SG, Lundy FT, et al
    Fusobacterium nucleatum and oral cancer: a critical review.
    BMC Cancer. 2021;21:1212.
    PubMed     Abstract available

  144. LI J, Yan T, Wu X, Ke X, et al
    Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    BMC Cancer. 2021;21:1205.
    PubMed     Abstract available

  145. ZHU X, Shanzhou Q, Li D, Pang X, et al
    PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis.
    BMC Cancer. 2021;21:1195.
    PubMed     Abstract available

  146. SHI K, Zhang JZ, Yang L, Li NN, et al
    Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:1196.
    PubMed     Abstract available

  147. NAGAKI Y, Motoyama S, Sato Y, Wakita A, et al
    Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
    BMC Cancer. 2021;21:1192.
    PubMed     Abstract available

  148. SUZUKI H, Sasaki E, Takano G, Goto S, et al
    Lymph node ratio as a predictor for minor salivary gland cancer in head and neck.
    BMC Cancer. 2021;21:1186.
    PubMed     Abstract available

  149. CHEN S, Lai H, Zhao J, Chen B, et al
    The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
    BMC Cancer. 2021;21:1183.
    PubMed     Abstract available

    October 2021
  150. ZHU Y, Yao W, Xu BC, Lei YY, et al
    Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
    BMC Cancer. 2021;21:1167.
    PubMed     Abstract available

  151. ROSVALL BR, Kostiuk M, Williams J, Matkin A, et al
    Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules.
    BMC Cancer. 2021;21:1142.
    PubMed     Abstract available

  152. CHEN Y, Huang Q, Chen J, Lin Y, et al
    Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.
    BMC Cancer. 2021;21:1130.
    PubMed     Abstract available

  153. KASSIR ZM, Li J, Harrison C, Johnson JT, et al
    Disparity of perception of quality of life between head and neck cancer patients and caregivers.
    BMC Cancer. 2021;21:1127.
    PubMed     Abstract available

  154. MERINO T, Pinto MP, Orellana MP, Martinez G, et al
    Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
    BMC Cancer. 2021;21:1114.
    PubMed     Abstract available

  155. MARTINO R, Fitch MI, Fuller CD, Hope A, et al
    The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
    BMC Cancer. 2021;21:1100.
    PubMed     Abstract available

  156. ZHANG QW, Wang JY, Qiao XF, Li TL, et al
    Variations in disease burden of laryngeal cancer attributable to alcohol use and smoking in 204 countries or territories, 1990-2019.
    BMC Cancer. 2021;21:1082.
    PubMed     Abstract available

  157. ZHOU Y, Zhang S, Min Z, Yu Z, et al
    Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    BMC Cancer. 2021;21:1085.
    PubMed     Abstract available

  158. MUHANNA N, Eu D, Chan HHL, Douglas C, et al
    Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    BMC Cancer. 2021;21:1075.
    PubMed     Abstract available

  159. HUANG Q, Shen YJ, Hsueh CY, Guo Y, et al
    miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:1074.
    PubMed     Abstract available

    September 2021
  160. LV X, Han S, Xu B, Deng Y, et al
    The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:1072.
    PubMed     Abstract available

  161. AUGUSTE A, Joachim C, Deloumeaux J, Gaete S, et al
    Head and neck cancer risk factors in the French West Indies.
    BMC Cancer. 2021;21:1071.
    PubMed     Abstract available

  162. KAWASHITA Y, Kitamura M, Soutome S, Ukai T, et al
    Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study.
    BMC Cancer. 2021;21:1064.
    PubMed     Abstract available

  163. CHENG S, Yang L, Dai X, Wang J, et al
    The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
    BMC Cancer. 2021;21:1057.
    PubMed     Abstract available

  164. TAGKALOS E, van der Sluis PC, Berlth F, Poplawski A, et al
    Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).
    BMC Cancer. 2021;21:1060.
    PubMed     Abstract available

  165. SHI C, Liu S, Tian X, Wang X, et al
    A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:1035.
    PubMed     Abstract available

  166. NIU C, Liu Y, Wang J, Liu Y, et al
    Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study.
    BMC Cancer. 2021;21:1034.
    PubMed     Abstract available

  167. TANIYAMA Y, Murakami K, Yoshida N, Takahashi K, et al
    Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study.
    BMC Cancer. 2021;21:1008.
    PubMed     Abstract available

  168. XIA T, Tian H, Zhang K, Zhang S, et al
    Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1003.
    PubMed     Abstract available

  169. WANG Y, Wang J, Chen Z, Ma M, et al
    Analysis of the correlation between high iodized salt intake and the risk of thyroid nodules: a large retrospective study.
    BMC Cancer. 2021;21:1000.
    PubMed     Abstract available

  170. LI R, Pang XF, Huang ZG, Yang LH, et al
    Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
    BMC Cancer. 2021;21:996.
    PubMed     Abstract available

  171. WANG ZY, Jiang YZ, Xiao W, Xue XB, et al
    Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
    BMC Cancer. 2021;21:988.
    PubMed     Abstract available

  172. ISHIZU T, Eichin D, Padzik A, Tuominen S, et al
    Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9.
    BMC Cancer. 2021;21:990.
    PubMed     Abstract available

  173. KHAIRAN P, Sobue T, Eshak ES, Zha L, et al
    Association of dietary intakes of vitamin B12, vitamin B6, folate, and methionine with the risk of esophageal cancer: the Japan Public Health Center-based (JPHC) prospective study.
    BMC Cancer. 2021;21:982.
    PubMed     Abstract available

  174. CHEN YH, Chen CH, Chien CY, Su YY, et al
    Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
    BMC Cancer. 2021;21:979.
    PubMed     Abstract available

    August 2021
  175. MINESAKI A, Kai K, Kuratomi Y, Aishima S, et al
    Infiltration of CD1a-positive dendritic cells in advanced laryngeal cancer correlates with unfavorable outcomes post-laryngectomy.
    BMC Cancer. 2021;21:973.
    PubMed     Abstract available

  176. MU G, Wang J, Liu Z, Zhang H, et al
    Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:960.
    PubMed     Abstract available

  177. LIU Z, Liu H, Dong Q, Li H, et al
    Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    BMC Cancer. 2021;21:951.
    PubMed     Abstract available

  178. LI G, Xia YF, Huang YX, Okat D, et al
    Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
    BMC Cancer. 2021;21:944.
    PubMed     Abstract available

  179. FENG G, Xu Y, Ma N, Midorikawa K, et al
    Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:929.
    PubMed     Abstract available

  180. LI X, Liu Z, Zhou W, Liu X, et al
    Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
    BMC Cancer. 2021;21:922.
    PubMed     Abstract available

  181. LI MX, Sun XM, Cheng WG, Ruan HJ, et al
    Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:906.
    PubMed     Abstract available

  182. FUJIMA N, Andreu-Arasa VC, Meibom SK, Mercier GA, et al
    Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
    BMC Cancer. 2021;21:900.
    PubMed     Abstract available

  183. MASAKI C, Sugino K, Kobayashi S, Hosoi Y, et al
    Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients.
    BMC Cancer. 2021;21:894.
    PubMed     Abstract available

  184. ZAHID N, Zahid W, Khalid W, Azam I, et al
    Resilience and its associated factors in head and neck cancer patients in Pakistan: an analytical cross-sectional study.
    BMC Cancer. 2021;21:888.
    PubMed     Abstract available

    July 2021
  185. HE Y, Liu Z, Sheng S, Gao W, et al
    Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?
    BMC Cancer. 2021;21:878.
    PubMed     Abstract available

  186. ROUTILA J, Suvila K, Grenman R, Leivo I, et al
    Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:868.
    PubMed     Abstract available

  187. SINGH P, Bennett B, Bailey T, Taylor-Stokes G, et al
    Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.
    BMC Cancer. 2021;21:854.
    PubMed     Abstract available

  188. CHEN W, Luo YK, Zhang Y, Song Q, et al
    Ultrasound-guided implantation of radioactive (125)I seed in radioiodine refractory differentiated thyroid carcinoma.
    BMC Cancer. 2021;21:834.
    PubMed     Abstract available

  189. ZHU C, Gu L, Liu Z, Li J, et al
    Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:836.
    PubMed     Abstract available

  190. LI H, Zhang X, Yi C, He Y, et al
    Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    BMC Cancer. 2021;21:835.
    PubMed     Abstract available

  191. LANG K, Adeberg S, Harrabi S, Held T, et al
    Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
    BMC Cancer. 2021;21:812.
    PubMed     Abstract available

  192. STRAUB M, Sigman DM, Auderset A, Ollivier J, et al
    Distinct nitrogen isotopic compositions of healthy and cancerous tissue in mice brain and head&neck micro-biopsies.
    BMC Cancer. 2021;21:805.
    PubMed     Abstract available

  193. ZHOU YJ, Lu XF, Meng JL, Wang XY, et al
    Neo-adjuvant radiation therapy provides a survival advantage in T3-T4 nodal positive gastric and gastroesophageal junction adenocarcinoma: a SEER database analysis.
    BMC Cancer. 2021;21:771.
    PubMed     Abstract available

    June 2021
  194. HE G, Pang R, Han J, Jia J, et al
    TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
    BMC Cancer. 2021;21:753.
    PubMed     Abstract available

  195. ITO T, Tsukahara K, Sato H, Shimizu A, et al
    Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
    BMC Cancer. 2021;21:742.
    PubMed     Abstract available

  196. MIYAWAKI Y, Sato H, Oya S, Sugita H, et al
    Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study.
    BMC Cancer. 2021;21:725.
    PubMed     Abstract available

  197. SANTERO M, Perez-Bracchiglione J, Acosta-Dighero R, Meade AG, et al
    Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews.
    BMC Cancer. 2021;21:712.
    PubMed     Abstract available

  198. BAKOS B, Kiss A, Arvai K, Szili B, et al
    Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
    BMC Cancer. 2021;21:706.
    PubMed     Abstract available

  199. SHI Y, Yang D, Qin Y
    Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:705.
    PubMed     Abstract available

  200. UEHARA K, Tanabe Y, Hirota S, Higa S, et al
    Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
    BMC Cancer. 2021;21:688.
    PubMed     Abstract available

  201. FU JY, Zhang CP, Zhang ZY
    Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer.
    BMC Cancer. 2021;21:663.
    PubMed     Abstract available

  202. DRAGAN T, Duprez F, Van Gossum A, Gulyban A, et al
    Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
    BMC Cancer. 2021;21:656.
    PubMed     Abstract available

  203. HOXHAJ I, Vukovic V, Boccia S, Pastorino R, et al
    Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
    BMC Cancer. 2021;21:660.
    PubMed     Abstract available

  204. CHEN WJ, Xu WN, Wang HY, Chen XX, et al
    Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    BMC Cancer. 2021;21:651.
    PubMed     Abstract available

    May 2021
  205. LIU W, Yu B, Luo Y, Li J, et al
    Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    BMC Cancer. 2021;21:639.
    PubMed     Abstract available

  206. HEFT NEAL ME, Birkeland AC, Bhangale AD, Zhai J, et al
    Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
    BMC Cancer. 2021;21:636.
    PubMed     Abstract available

  207. LI X, Fang Q, Du W, Zhang X, et al
    Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:622.
    PubMed     Abstract available

  208. MUKHERJEE K, Sur D, Singh A, Rai S, et al
    Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    BMC Cancer. 2021;21:628.
    PubMed     Abstract available

  209. FANG X, Wang S, Zhao J, Zhang Y, et al
    A population-based analysis of clinical features and lymph node dissection in head and neck malignant neurogenic tumors.
    BMC Cancer. 2021;21:598.
    PubMed     Abstract available

  210. CHEN Y, Hu N, Liao L, Yu K, et al
    ABO genotypes and the risk of esophageal and gastric cancers.
    BMC Cancer. 2021;21:589.
    PubMed     Abstract available

  211. O'CONNOR L, Smyth E, Bennett AE, Smith V, et al
    Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review.
    BMC Cancer. 2021;21:586.
    PubMed     Abstract available

  212. MAGHSOOMI Z, Emami Z, Malboosbaf R, Malek M, et al
    Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.
    BMC Cancer. 2021;21:579.
    PubMed     Abstract available

  213. QUINTANILHA JCF, Cursino MA, Borges JB, Torso NG, et al
    MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
    BMC Cancer. 2021;21:575.
    PubMed     Abstract available

  214. QIN M, Han F, Wu J, Gao FX, et al
    KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPbeta transcription.
    BMC Cancer. 2021;21:559.
    PubMed     Abstract available

  215. GURIZZAN C, Lorini L, Paderno A, Tomasoni M, et al
    Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
    BMC Cancer. 2021;21:561.
    PubMed     Abstract available

  216. MEI X, Yao X, Feng F, Cheng W, et al
    Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
    BMC Cancer. 2021;21:543.
    PubMed     Abstract available

  217. BEYENE ET, Ketema SG, Alebachew AN, Saleh MY, et al
    Descriptive epidemiology of nasopharyngeal carcinoma at Tikur Anbessa Hospital, Ethiopia.
    BMC Cancer. 2021;21:540.
    PubMed     Abstract available

  218. YANG JH, Sun XS, Xiao BB, Liu LT, et al
    Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
    BMC Cancer. 2021;21:534.
    PubMed     Abstract available

  219. CHEN J, Xia YJ, Liu TY, Lai YH, et al
    Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    BMC Cancer. 2021;21:532.
    PubMed     Abstract available

  220. XU Y, Wu Z, Ye W, Xiao Y, et al
    Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:519.
    PubMed     Abstract available

  221. ARSA L, Siripoon T, Trachu N, Foyhirun S, et al
    Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    BMC Cancer. 2021;21:504.
    PubMed     Abstract available

    April 2021
  222. ALMANGUSH A, Alabi RO, Troiano G, Coletta RD, et al
    Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:480.
    PubMed     Abstract available

  223. ZHANG X, Song X, Lai Y, Zhu B, et al
    Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
    BMC Cancer. 2021;21:483.
    PubMed     Abstract available

  224. KUNZ V, Wichmann G, Lehmann-Laue A, Mehnert-Theuerkauf A, et al
    Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study.
    BMC Cancer. 2021;21:478.
    PubMed     Abstract available

  225. JENSEN CB, Saucke MC, Pitt SC
    Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.
    BMC Cancer. 2021;21:471.
    PubMed     Abstract available

  226. WONG TJ, Li Q, Dodd V, Wang W, et al
    Oral cancer knowledge and screening behavior among smokers and non-smokers in rural communities.
    BMC Cancer. 2021;21:430.
    PubMed     Abstract available

  227. DUAN X, Shang X, Yue J, Ma Z, et al
    A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:431.
    PubMed     Abstract available

  228. ZHOU LQ, Hu Y, Xiao HJ
    The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:424.
    PubMed     Abstract available

  229. DING Y, Jiang R, Chen Y, Jing J, et al
    Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
    BMC Cancer. 2021;21:420.
    PubMed     Abstract available

  230. WEI M, Zhao L, Lv J, Li X, et al
    The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:415.
    PubMed     Abstract available

  231. BOGUSZEWICZ L, Bielen A, Jarczewski JD, Ciszek M, et al
    Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics.
    BMC Cancer. 2021;21:410.
    PubMed     Abstract available

  232. SAENTHAVEESUK P, Yang L, Zeng B, Xu M, et al
    Development and validation of multiparametric MRI-based nomogram for predicting occult metastasis risk in early tongue squamous cell carcinoma.
    BMC Cancer. 2021;21:408.
    PubMed     Abstract available

  233. WANG Y, Zhang X, Zhang X, Liu-Helmersson J, et al
    Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
    BMC Cancer. 2021;21:403.
    PubMed     Abstract available

  234. ZHOU Z, Wu W, Li J, Liu C, et al
    Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:395.
    PubMed     Abstract available

  235. BERNADACH M, Lapeyre M, Dillies AF, Miroir J, et al
    Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
    BMC Cancer. 2021;21:360.
    PubMed     Abstract available

  236. NIE Z, Zhao P, Shang Y, Sun B, et al
    Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.
    BMC Cancer. 2021;21:372.
    PubMed     Abstract available

  237. ZHU Q, Xu D
    Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    BMC Cancer. 2021;21:344.
    PubMed     Abstract available

  238. ZHENG W, Chen C, Yu J, Jin C, et al
    An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
    BMC Cancer. 2021;21:345.
    PubMed     Abstract available

    March 2021
  239. CHOI KH, Song JH, Park EY, Hong JH, et al
    Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
    BMC Cancer. 2021;21:317.
    PubMed     Abstract available

  240. PHAM DX, Nguyen HD, Phung AHT, Bui TD, et al
    Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.
    BMC Cancer. 2021;21:296.
    PubMed     Abstract available

  241. LI C, Tao C, Bai T, Li Z, et al
    Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery systems using automated planning.
    BMC Cancer. 2021;21:261.
    PubMed     Abstract available

  242. ZHANG S, Zhang R, Wang C, Gong W, et al
    Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.
    BMC Cancer. 2021;21:225.
    PubMed     Abstract available

    February 2021
  243. CHOI SY, Lee E, Kim E, Chung MK, et al
    Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
    BMC Cancer. 2021;21:178.
    PubMed     Abstract available

  244. WENTER V, Albert NL, Ahmaddy F, Unterrainer M, et al
    The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.
    BMC Cancer. 2021;21:139.
    PubMed     Abstract available

  245. LIANG YJ, Mei XY, Zeng B, Zhang SE, et al
    Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:122.
    PubMed     Abstract available

    January 2021
  246. KONDO S, Hirakawa H, Ikegami T, Uehara T, et al
    Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:87.
    PubMed     Abstract available

  247. SOLIS-PAZMINO P, Salazar-Vega J, Lincango-Naranjo E, Garcia C, et al
    Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    BMC Cancer. 2021;21:42.
    PubMed     Abstract available

    December 2020
  248. KATAGIRI T, Ohyama Y, Miyamoto H, Egawa Y, et al
    Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control.
    BMC Cancer. 2020;20:1216.
    PubMed     Abstract available

  249. DATAR S, Cabanillas M, Dadu R, Ost D, et al
    Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents.
    BMC Cancer. 2020;20:1181.
    PubMed     Abstract available

    November 2020
  250. KALISZEWSKI K, Diakowska D, Nowak L, Wojtczak B, et al
    The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
    BMC Cancer. 2020;20:1166.
    PubMed     Abstract available

  251. XIE Z, Li X, He Y, Wu S, et al
    Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
    BMC Cancer. 2020;20:1143.
    PubMed     Abstract available

  252. KANG HY, Kim I, Kim YY, Bahk J, et al
    Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study.
    BMC Cancer. 2020;20:1096.
    PubMed     Abstract available

    October 2020
  253. GU B, Fang Q, Wu Y, Du W, et al
    Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival.
    BMC Cancer. 2020;20:1034.
    PubMed     Abstract available

  254. HOSHINO I, Nabeya Y, Takiguchi N, Gunji H, et al
    Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
    BMC Cancer. 2020;20:1007.
    PubMed     Abstract available

  255. AN YZ, Cho E, Ling J, Zhang X, et al
    The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
    BMC Cancer. 2020;20:987.
    PubMed     Abstract available

  256. ZHU L, Dong L, Feng M, Yang F, et al
    Profiles of autophagy-related genes in esophageal adenocarcinoma.
    BMC Cancer. 2020;20:943.
    PubMed     Abstract available

    September 2020
  257. ELHALAWANI H, Mohamed ASR, Elgohari B, Lin TA, et al
    Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:912.
    PubMed     Abstract available

  258. IZKHAKOV E, Keinan-Boker L, Barchana M, Shacham Y, et al
    Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: an Israeli population-based study.
    BMC Cancer. 2020;20:892.
    PubMed     Abstract available

  259. LORENZEN S, Biederstadt A, Ronellenfitsch U, Reissfelder C, et al
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
    BMC Cancer. 2020;20:886.
    PubMed     Abstract available

  260. YOON JY, Brezden-Masley C, Streutker CJ
    Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    BMC Cancer. 2020;20:860.
    PubMed     Abstract available

  261. ALMANGUSH A, Makitie AA, Hagstrom J, Haglund C, et al
    Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
    BMC Cancer. 2020;20:843.
    PubMed     Abstract available

    August 2020
  262. ZHANG B, Gao S, Li R, Li Y, et al
    Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    BMC Cancer. 2020;20:815.
    PubMed     Abstract available

  263. TU XP, Li H, Chen LS, Luo XN, et al
    OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:794.
    PubMed     Abstract available

  264. ZENG H, Song X, Ji J, Chen L, et al
    HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    BMC Cancer. 2020;20:796.
    PubMed     Abstract available

  265. CHEN C, Chen S, Cao H, Wang J, et al
    Prognostic significance of autophagy-related genes within esophageal carcinoma.
    BMC Cancer. 2020;20:797.
    PubMed     Abstract available

  266. LEERS JM, Knepper L, van der Veen A, Schroder W, et al
    The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    BMC Cancer. 2020;20:781.
    PubMed     Abstract available

  267. CIAPPUCCINI R, Heutte N, Lasne-Cardon A, Saguet-Rysanek V, et al
    Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
    BMC Cancer. 2020;20:765.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.